Safety of Lesion Deferral with iFR or FFR in Both Stable and Acute Patients

Overall, deferral of lesion revascularization is equally safe with both fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR), with a low rate of events of about 4%. Lesions were more frequently deferred when iFR (as opposed to FFR) was used for functional assessment. Among patients with deferred lesions, acute patients experienced significantly more events than stable chronic patients.

Nuevo dispositivo para medición del FFR permite cruzar la lesión con nuestra guía preferidaThis study analyzed the safety of lesion deferral in the randomized populations (n = 4486) of the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) and iFR-SWEDEHEART (Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve in Patients With Stable Angina Pectoris or Acute Coronary Syndrome) trials.

 

Patients were stratified according to whether the revascularization decision was made on the basis of iFR or FFR and to clinical presentation (acute coronary syndrome and stable chronic disease).


Read also: Predictors of Conduction Disturbances Requiring a Late Permanent Pacemaker.


The primary endpoint was a composite of major adverse events (all-cause death, non-fatal infarction, and unplanned revascularization at one year).

 

Coronary revascularization was deferred in 2130 total patients: 1117 patients (50%) in the iFR group and 1013 patients (45%) in the FFR group (p < 0.01).


Read also: Ambulatory Continuous Monitoring in Patients with Left Bundle Branch Block After TAVI.


At 1 year, the rate of events in the population with deferred vessels was similar between the iFR and FFR groups (4.12% vs. 4.05%; p = 0.6). Among the deferred population, clinical presentation as acute coronary syndrome was associated with more events compared with chronic stable patients (5.91% vs. 3.64%; p = 0.04).

 

Conclusion

Deferral of revascularization is equally safe with both iFR and FFR, with a low event rate of around 4%. Lesions were more commonly deferred when iFR was used. After lesion deferral, patients with an acute coronary syndrome experienced more combined events than patients with stable chronic angina.

 

Original title: Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes.

Reference: Javier Escaned et al. J Am Coll Cardiol Intv 2018; 11:1437-49.

 

2018-10-18-1437abierto.full


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...